research use only
Cat.No.S5109
| Related Targets | Dehydrogenase HSP Transferase P450 (e.g. CYP17) PDE phosphatase PPAR Vitamin Carbohydrate Metabolism Mitochondrial Metabolism |
|---|---|
| Other Endogenous Metabolite Inhibitors | 4-HNE (4-Hydroxynonenal) Heparan Sulfate Sodium L-lactate 3-Hydroxybutyric acid (BHB acid) |
|
In vitro |
DMSO
: 80 mg/mL
(200.78 mM)
Water : 80 mg/mL Ethanol : Insoluble |
|
In vivo |
|||||
Step 1: Enter information below (Recommended: An additional animal making an allowance for loss during the experiment)
Step 2: Enter the in vivo formulation (This is only the calculator, not formulation. Please contact us first if there is no in vivo formulation at the solubility Section.)
Calculation results:
Working concentration: mg/ml;
Method for preparing DMSO master liquid: mg drug pre-dissolved in μL DMSO ( Master liquid concentration mg/mL, Please contact us first if the concentration exceeds the DMSO solubility of the batch of drug. )
Method for preparing in vivo formulation: Take μL DMSO master liquid, next addμL PEG300, mix and clarify, next addμL Tween 80, mix and clarify, next add μL ddH2O, mix and clarify.
Method for preparing in vivo formulation: Take μL DMSO master liquid, next add μL Corn oil, mix and clarify.
Note: 1. Please make sure the liquid is clear before adding the next solvent.
2. Be sure to add the solvent(s) in order. You must ensure that the solution obtained, in the previous addition, is a clear solution before proceeding to add the next solvent. Physical methods such
as vortex, ultrasound or hot water bath can be used to aid dissolving.
| Molecular Weight | 398.44 | Formula | C15H22N6O5S |
Storage (From the date of receipt) | 3 years -20°C powder (seal) |
|---|---|---|---|---|---|
| CAS No. | 29908-03-0 | Download SDF | Storage of Stock Solutions |
|
|
| Synonyms | AdoMet, S-Adenosylmethionine, SAMe | Smiles | C[S+](CCC(C(=O)[O-])N)CC1C(C(C(O1)N2C=NC3=C(N=CN=C32)N)O)O | ||
| In vitro |
Ademetionine (S-adenosylmethionine; SAMe) is a ubiquitous metabolite present in all cells and biological fluids, and serves as a methyl donor in a multitude of different methylation reactions involving proteins, phospholipids, catecholamines and DNA.
|
|---|---|
| In vivo |
SAMe is able to cross the intestinal wall and increase plasma levels. Studies in rats reveal that absorption of the drug is much better after intraduodenal administration compared to oral administration. The systemic bioavailability after oral SAMe administration appears to be low. SAMe dose-dependently (12.5, 25, 50, 100 and 200 mg/kg sc.) decreases immobility time in the forced swimming test in mice and rats. Chronic treatment with SAMe is associated with an increase in density of b-receptors, and a decrease in the affinity of a1 adrenoceptors for phenylephrine in rat cerebral membranes.
|
References |
(data from https://clinicaltrials.gov, updated on 2024-05-22)
| NCT Number | Recruitment | Conditions | Sponsor/Collaborators | Start Date | Phases |
|---|---|---|---|---|---|
| NCT05312372 | Withdrawn | Esophageal Squamous Cell Carcinoma |
Institut de Recherches Internationales Servier|ADIR a Servier Group company|Servier |
May 2025 | Phase 1|Phase 2 |
| NCT05775718 | Recruiting | Bone Marrow Transplant|Stem Cell Transplant |
University of Colorado Denver|GlaxoSmithKline |
December 1 2024 | Phase 2 |
| NCT05279196 | Not yet recruiting | Muscle Injury |
University Hospital Montpellier |
September 2024 | Not Applicable |
| NCT06309173 | Not yet recruiting | Multiple Sclerosis |
University Hospital Basel Switzerland |
September 2024 | -- |
| NCT06251999 | Not yet recruiting | Elderly Patients |
Shanghai 6th People''s Hospital |
August 1 2024 | Phase 4 |
| NCT06280742 | Not yet recruiting | Multiple Sclerosis |
Assistance Publique - Hôpitaux de Paris |
July 1 2024 | Not Applicable |
Tel: +1-832-582-8158 Ext:3
If you have any other enquiries, please leave a message.